Hubei TuoChu Kangyuan Pharmaceutical

Hubei Tuochu Kangyuan Pharmaceutical is a Chinese pharmaceutical company headquartered in the Jingzhou Development Zone of Hubei Province. Founded in 2011, the company focuses on the research, development, and large-scale manufacturing of chemical active pharmaceutical ingredients (APIs) and finished drug products. Its commercial portfolio primarily targets chronic conditions such as hypertension and type 2 diabetes, alongside a range of anti-infective and gastrointestinal medications. The company operates modern, GMP-certified production lines for oral solid dosages, including tablets, capsules, and granules. Tuochu Kangyuan serves as a significant supplier in the domestic Chinese market and provides contract manufacturing services for international clients.